Avita Medical | 1811094D - Pre Tax Profit

Stock Price
1.09
Daily Change
-0.05 -3.96%
Monthly
4.31%
Yearly
-62.67%
Q1 Forecast
1.06

Avita Medical reported AUD-23.77M in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Celltrion KRW 14.6B 180.89B Jun/2025
Clinuvel Pharmaceuticals AUD 35.87M 21.07M Jun/2024
Cochlear AUD 121.1M 155.6M Jun/2025
CSL USD 1.4B 1.14B Jun/2025
Cspc Pharmaceutical CNY 1.21B 110.04M Sep/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Divis Laboratories Ltd INR 9.12B 1.79B Sep/2025
Kangmei Pharma CNY 2.07M 13.77M Sep/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Mayne Pharma AUD -14.7M 42.91M Dec/2024
Medical Developments International AUD -149K 466K Jun/2025
Nanosonics AUD 11.39M 487K Jun/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Organigram Holdings CAD -41.72M 25.52M Sep/2025
Pacific Edge NZD -714K 49K Mar/2024
Pharma Mar EUR -4.08M 27.43M Sep/2025
Polynovo AUD 1.82M 3.89M Jun/2025
PYC Therapeutics AUD -12.57M 13.3M Jun/2025
Qiagen NV USD 134.73M 7.91M Sep/2025
Ramsay Health Care AUD 103.75M 54.35M Jun/2025
ResMed USD 496.15M 13.77M Dec/2025
Sartorius EUR 85M 14.1M Sep/2025
Telix Pharmaceuticals AUD 76.73M 66.04M Jun/2025
Tilray USD -1.39B 600.71M Mar/2025
Zz Pientze Pharmaceu CNY 523.11M 659.54M Jun/2025